Not Yet RecruitingNCT06758596
Mood, behavior and brain responses to THC
About this title
Read the official source — NCT06758596Medication studyAges 18–21United StatesAddiction
Understand this study
Who could participate?
Listed age limits: 18 years to 21 years.
- Listed locations
- ChicagoSee all locations and recruitment
- Study phase
- Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: January 4, 2027
- Recruitment status
- Not Yet Recruiting
- Enrollment listed in the registry
- 144
- Sponsor
- University of Illinois Chicago
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
- Locations
- United States
- Age range
- From 18 Years to 21 Years
- Official registry ID
- NCT06758596
- Official title
Show the full official title
Research Investigating Drug Effects-2 (RiDE-2)
Recruitment & locations
Not yet recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Chicago
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Illinois Chicago, a university.
Does this study involve medication?
Yes. The study involves medication, including Placebo Oral Capsule and THC.
Who can participate?
Listed age limits: 18 years to 21 years.
Is this study still recruiting?
The registry lists this study as not yet recruiting.
